The recent legalization of industrial hemp in Ghana is likely to open up significant economic,environmental, and health opportunities. Given that the youth (15 to 35 years) make up 38.2%of the total population and contribute significantly to the country’s economic growth anddevelopment, understanding the implications of this legalization on youth health is crucial.This article aims to identify and discuss the health implications of industrial hemp legalizationin Ghana, focusing specifically on its impact on the youth. Industrial hemp legalization inGhana could lead to both positive and negative health outcomes. On the positive side, extensiveresearch and innovation could unlock the therapeutic potential of industrial hemp, contributingto the management of prevalent diseases such as malaria, epilepsy, sickle cell disease, diabetes,and prostate and breast cancers. Additionally, hemp seeds, renowned for their essential nutrientcontent, could address malnutrition issues among Ghanaian youth when incorporated into theirdiet. Moreover, there are indirect benefits, including economic and environmental advantages,that could further improve youth health. These benefits could ultimately enhance productivityand foster economic growth. However, the abuse and misuse of industrial hemp or hemp-basedproducts could pose potential risks, such as addiction and accidental or excessive consumption,as well as mental disorders like anxiety, psychosis, and depression. To address these potentialrisks, robust regulatory frameworks are essential. These frameworks should prioritizepromoting research, addressing public health concerns, and fostering stakeholder engagement.Considering the potential of industrial hemp legalization to improve youth health andcontribute to economic development, alongside the potential adverse health consequences, it isimperative for policymakers to develop effective, evidence-based regulatory frameworks andpolicies. This approach will help maximize benefits and minimize negative impacts.
No takes yet. Share an insight, caveat, or question.
Richard Quansah Amissah (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: